PRESSOR SUBSTANCES IN ARTERIAL HYPERTENSION : V. CHEMICAL AND PHARMACOLOGICAL CHARACTERISTICS OF PHERENTASIN by Schroeder, Henry A. et al.
PRESSOR  SUBSTANCES  IN  ARTERIAL  HYPERTENSION 
W.  CHEMICAL  AND  PHARMACOLOGICAL  CHARACTERISTICS  OF  PHERENTASIN* 
BY  HENRY  A.  SCHROEDER,  M.D.,  H.  MITCHELL  PERRY,  JR.,  M.D., 
EVIE  G.  DENNIS,  AND LAURA E.  MAHONEY 
(From the Hypertension  Division,  Department  of Internal  Medidne,  Washington 
University School of Medicine, and Barnes Hospital, St. Louis) 
(Received for publication, April 27, 1955) 
A  substance which is prolongedly pressor in the hypertensive rat has been 
repeatedly obtained from human hypertensive arterial blood but not usually 
from normotensive blood (1-9). This pressor substance has been called "phe- 
rentasin." Various inactivation procedures have indicted  that it is a  dialyz- 
able primary amine, apparently non-phenolic, which is inactivated by nitrous 
acid, ketene, alkali and monamine oxidase (10), and that it might contain a 
carbonyl group. The substance exhibits a high pressor potency and only small 
amounts can be obtained from large quantities of arterial blood. The  irregu- 
larities of the rat assay method which uses most of that obtained from a single 
patient for detection of its presence has made accumulation of sufficient quan- 
tities for direct chemical analysis difficult if not impossible. A better method 
of assay was therefore desirable. 
This communication describes the results obtained with a new assay method 
which detects small quantities of a constrictor substance believed to be identi- 
cal with pherentasin. Its pharmacology, chemical stability, and resistance or 
susceptibility to inactivation are discussed in an attempt to show what known 
vasoactive substances are not pherentasin and to throw some new light upon 
its chemical nature. The structure of the material has decided clinical impor- 
tance in view of the newer successful therapeutic methods employed in con- 
trolling human hypertension (11). 
Method and Materials 
The assay method chosen was that of Furchgott  (12).  Briefly, the aorta from a  freshly 
killed rabbit was cut spirally into a  long strip and suspended  in a  bath containing 20 ml. 
oxygenated  Krebs-Ringer  solution  maintained  constantly  at  37°C.  by  a  thermostatically 
controlled water  bath.  A  simple weighted lever and ink writer recorded contractions on a 
slowly revolving drum. 2 to 3 hours were required for a fresh strip to relax to a steady state. 
Before substances were tested, 0.2 ml. of 0.001  ~¢ ethylenediaminetetraacetate was added to 
* Work done under a grant-in-aid from the National Heart Institute, United States Public 
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the bath in order to chelate trace metals (especially copper) in the water which catalyze the 
oxidation of norepinephrine and other substances.  Since the aortic strip  was relaxed  at the 
outset of each experiment, further lengthening did not usually occur unless the preparation 
was killed; constriction (shortening) of the vascular smooth muscle was therefore the criterion 
of activity of a  test substance and relaxation after constriction that of an antagonist.  The 
preparation  remained active for 8 to  12 hours.  Each  test was done in quadruplicate,  four 
preparations from the same rabbit being run simultaneously. As repeated washing of the bath 
removed most active substances from the muscle (save dibenamine), several tests were done 
on the same preparation. All strips were tested for contractility at the beginning and end of 
the experiment with norepinephrine in a final concentration of 10s (2.0 "r in 20 ml.). When 
the effects of known  compounds  were being evaluated,  each was  tested  separately  on  the 
system and upon its response to norepinephrine. 
Three pooled collections of blood drawn directly into alcohol were processed for pherenta- 
sin as previously described (3), being evaporated in a 60 gallon still by Monsanto Chemical 
Company and purified on ion exchange resins (5). The active extract from 17.54 liters hyper- 
tensive arterial blood was concentrated  15  times that  of the original blood in isopropanol 
without drying at any of the 15 steps of the processing. A second,  from 16.8 liters hyperten- 
sive arterial blood, was dried (step 16) and dissolved in dilute hydrochloric acid at a concen- 
tration  100 times that of the original blood. A  third, from 16.0 liters normotensive venous 
blood was  concentrated  400  times without  drying at  step  16  of the processing.  Standard 
methods in use for 10 years were followed  (4). 
Although venous blood has been shown to contain less of the active pherentasin than arte- 
rial blood  (3),  the sensitivity of the rabbit aortic strip permitted an assay of small samples 
from  hypertensive  patients.  Therefore, 20  to 30 ml.  of venous  blood was drawn  directly 
into six volumes of cold ethanol, filtered, acidified,  evaporated in ~acuo to a concentration of 
twice the original one, refiltered and stored in the deep freeze before testing. In a few instances 
heparinized blood was tested directly, but foaming in the oxygenated bath made the prepara- 
tion messy. 
Concentrations of drugs are given as that concentration finally obtained in the bath ac- 
cording to weight. Concentrations of simpler substances are given as that concentration finally 
attained in terms of molarity. The active pooled extract was always tested in 1.0 ml. amounts, 
the equivalent of 15 ml. of whole blood, while venous blood extracts in 1.0 ml. amounts were 
the equivalent of 2.0 ml. of original blood. 
Patients were divided into two groups,  those receiving hydralazine and  those receiving 
ganglionic blocking agents,  reserpine,  or no medication. This differentiation was important 
in view of the reported inactivation of pherentasin in the anesthetized rat  by hydralaxine 
(13). Normotensive subjects were hospital personnel and medical students.  In an evaluation 
of venous blood extracts, reactions of the strip were graded as negative (0 to 1 mm. rise on 
the paper), slight (1 to 3 ram. rise),  moderate (3 to 5 mm. rise),  marked (5 to 25 mm. rise). 
Tests made in the whole anesthetized rat followed  the routine method previously described 
(3). 
Results on Various Samples 
The active principle caused a  slowly developing, prolonged contraction of the 
aortic muscle,  which reached its height in  15  to  70 minutes and persisted un- 
til  the  strip  was  repeatedly  washed  with  fresh  solution,  after  which  a  slow 
recovery occurred.  This type of response  is termed  the  "slow reaction." Nor- 
epinephrine  on the other hand  caused a  rapid  contraction,  reaching its height 
in 5  to 8 minutes and persisting until washing quickly reversed it. This type of SCHROEDER, PEKR¥, DENNIS~ AND MAItONEY  321 
response is called the "rapid reaction"; it was produced by most known pri- 
mary amines and by potassium (Fig. 1). 
Venous Blood.--Untreated venous blood (1.0 ml.) was applied to a  strip as 
soon as possible after drawing. Four samples from normotensive subjects gave 
no reaction. One caused a  rapid reaction identical to that of epinephrine or 
norepinephrine; considerable pain was caused in drawing this sample because 
of small veins; the subject complained of palpitation and showed tachycardia, 
a transiently elevated systolic pressure, circumoral pallor, and sweating. Alco- 
holic extracts of the sample were inactive. Blood from two untreated hyper- 
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FIG.  1. Diagrammatic representation of rates of reaction of rabbit's aortic strip to nor- 
epinephrine and potassium ion, angiotonin, and active extract of hypertensive arterial blood 
traced from representative curves. The effect of hydralazine and of repeated washing of the 
strip with Krebs-Ringer  solution is shown. Note the slow contraction and relaxation produced 
by pherentasin in the extract. Large quantities of hydralazine were necessary to depress the 
reaction after it had occurred, although inhibition was produced by mixing the two sub- 
stances before testing, 
tensive patients caused slow reactions while that from two did not. Activity 
was lost on standing overnight in the cold. 
Venous Blood Extracts.--Alcoholic  acidified extracts were obtained from 18 
normotensive subjects: 14 were totally inactive, 3  showed slight activity, and 
one moderate constrictive effects. This last was obtained from a resident phy- 
sician who had a record of mild intermittent hypertension disclosed to us after 
the results of the test were known. Extracts from 28 untreated hypertensive 
patients of all degrees of severity showed marked slow reactions in 8, moderate 
in  1,  slight  in 6,  and no reaction in  13  cases.  The negative reactions were 
given by extracts from patients  with  milder stages  of the disease.  Extracts 
from 15 other patients treated with hydralazine gave marked reactions in  2, 
moderate in 2, and none in 11. 
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acidified isopropanol  extract  always caused  a  marked  slow  reaction  in  all 
strips  tested  (approximately 400).  Acidified isopropanol  itself gave  no  de- 
monstrable reaction and the pH  of the buffered Krebs-Ringer solution was 
unaffected. The  second  (hypertensive but  dried)  and  third  (normotensive) 
extracts were inactive in similar concentrations. 
Effect of Hydralazine  on Activlty.--Three patients in malignant stages gave 
venous blood extracts which were strongly positive. Mter control of the hy- 
pertension by treatment with ganglionic blocking agents and hydralazine (10, 
11)  for 10  to  14 days,  their normotensive blood extracts no longer showed 
constrictor activity. 
Pkarmacological Inactivation I 
The Active PooL--Attempts were made to ascertain whether or not the ac- 
tive material resembled known primary amines or other constrictor substances 
by observing the effect of mixing certain blocking agents with the material 
both before and after it was put on the strip. 
(a) Regitine (2[N-p'-tolyl-N-(m'-hydroxyphenyl)-aminomethyl]-imidazoline) 
in final concentrations of  10  -8 to 10-  8 by weight blocks and reverses the ac- 
tions of norepinephrine, epinephrine, and tyramine. Little or no decrease in 
constriction was produced by this agent  immediately after adding it to the 
bath; in 5 of 15 experiments 30 to 45 per cent depression occurred only after 
30 to 60 minutes while in the remainder no late changes were seen. 
(b)  Dihydroergotamine (10-  5)  blocks  norepinephrine,  epinephrine,  seroto- 
nin, and tryptamine. No blockade occurred; in fact, constriction was slightly 
enhanced. 
(c)  Iproniazid  (isonicotinyl isopropyl hydrazide)  (10  -5)  enhances the con- 
strictor action of tyramine. Actually it slightly decreased constriction already 
caused by the active material. 
(d)  Cocaine (2 X  10-  7) enhances the activity of epinephrine. No effect on 
the active material was observed. 
(e)  Dibenamine  (N,N-dibenzyl-/~-chloroethylamine)  (10-  s  to  10-  8)  pro- 
longedly blocks the receptivity of the aortic strip to norepinephrine, epineph- 
rine,  serotonin,  tryptamine,  and  isoamylamine and  partly  blocks  the  con- 
strictor action of histamine. It caused no change in the activity of the material. 
(f) Pyribenzamine (2-[benzyl(2-dimethylaminoethyl)amino]pyridine) (10  "-6) 
blocks the activity of histamine. It did not affect that of the active material. 
(g)  Atropine  (10-  7)  had no effect on the activity of the material; at high 
concentrations (10- 8  ) it was slightly depressor. 
(h)  Hydralazine (1-hydrazinophthalazine)  (2 X  10-  ~ to  5 X  10-  5)  inacti- 
vated the material slowly after the reaction had developed. When put on the 
1 Many of the statements in this section on the effects of known drugs on primary amines 
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strip first, this drug (2.5 ×  10  °5) prevented activity of the extract. It also in- 
hibited  histamine,  tryptamine,  tyramine, gnanidine,  and  norepinephrine  at 
much smaller concentrations. Guanidine (1003), for example, was completely 
and rapidly inactivated by 10  -v hydralazine. 
Therefore, the total activity of the material was not due to any of the above 
primary amines in the free state, although their presence in combined form 
could not be excluded. Hydralazine was the only one of these drugs  which 
appeared to inactivate the material. 
Material  in  Venous Blood.--A  few similar  studies  were made on  active 
single samples, concentrated twice, obtained from hypertensive patients. 
(a)  Dihydroergotamine (10  -5)  did not block the constrictor action of the 
simple extract of blood from a patient with malignant hypertension; actually 
moderate enhancement occurred in three of four experiments, similar to that 
observed with the active pool. 
(b)  Hydralazine (5)<  100  7)  completely blocked the active material in all 
ten bloods tested, whether mixed previously or added to the bath after con- 
striction was maximal. 
(¢)  Cocaine (10  -v)  enhanced slightly the activity of three samples and did 
not affect that of four others. 
(d) Pyribenzamine (10  -8) did not affect the activity of two samples. 
Chemical Inactivation 
Chemical  Spot  Tests.--Samples  of  the  two  hypertensive  pooled  extracts 
were dried in vavuo. The partly purified dried material, a  grayish amorphous 
powder, contained solids amounting to 15 rag. per 100 ml. of original blood. 
Standard  spot chemical analyses performed by Mr.  John  Cary showed the 
presence  of an aliphatic NI-I2 radical by two tests,  and considerable sulfur, 
but no carbonyl, alcohol, hydroxyl, sulfhydryl, C -- S or phenol groups (Table 
I). Both batches yielded the same results. 
On  paper  chromatograms made  in  butanol-water mixtures,  all  three  ex- 
tracts produced three identically colored ninhydrin-sensitive spots with the 
same Rf values of 0.2 or less. The active extract contained three others with 
values of 0.33, 0.42, and 0.523 The inactive (hypertensive, dried) extract dem- 
onstrated one extra spot with an Rf of 0.27,  while the third,  (normotensive 
venous)  showed five others,  with values of 0.24,  0.29,  0.35,  0.42,  and 0.74. 
Therefore, drying caused  the  disappearance  of both activity and  the more 
hydrophilic substances. 
Five of these six spots have been found in all active extracts, even after much greater 
purification than was done to the material here tested (5). Counter-current  partition chro- 
matography (200 plates), performed  by Merck and Co., Inc., separated the ninhydrin-sensi- 
five material into the first 20 plates but the five spots remained together. It is possible, there- 
fore, that hydrolysis  of a polypeptide  occurred during paper chromatography. 324  PRESSOR SUBSTANCES IN  ARTERIAL HYPERTENSION.  V 
Effect of Drying.--The dried sample was found to lack pressor effect; in fact, 
it was depressor in the rat and somewhat inhibitory of epinephrine on the aortic 
TABLE  I 
Analytical  and  Inactivation  Studies  on  Pk~r~a~n 
Procedure 
Spot Chemical Analyses* 
Liters blood/milliliter  extract 
Dissolved solids 
RCH20H 
P~CHOH 
C=0 
Reactive CH2 or NH~ 
Aliphatic RNI-I~ 
Phenol 
S 
C=S 
CSH 
Physical Measures 
Drying 
Heat at pH 8.8 
Heat at pH 2.0 
Heat at pH 7.6 
Chemical Measures 
Nitrous acid 
Ninhydrin 
Hydralazine 
Semicarbazide 
Hydroxylamine 
Enzymatic Inactivation 
Amine oxidase (kidney) 
Tyrosinase (potato) 
Pepsin,  trypsin,  chymo- 
trypsin, papain, protease, 
carboxypeptidase 
Papain +  cysteine 
Result or change  in 
activity 
1/10 
1.48per cent 
0 
0 
0 
+ 
+ 
0 
0.5 per cent 
0 
0 
Inactive 
Inactive 
0 
--50 per cent 
Inactive 
Inactive 
Inactive 
Rapid reaction 
Rapid reaction 
Inactive 
0 
Inactive 
Method or Remarks 
Two Batckes Identical 
Conversion to alkali  xanthates 
tt  It  ~t  t¢ 
Phenylhydrazine reaction 
Naphthoquinone test 
Fluorescence with fluorescein chloride 
in ultraviolet light 
Millon's test 
Lassaigne's test 
Iodine-azide reaction producing Nt 
t#  tt  tt  ~c 
Rapid oxidation in air 
? Primary amine 
Partial hydrolysis ? 
Primary amine 
Primary terminal amine 
Color formed 
? Carbonyl linkage 
Primary terminal amine 
No  mono-  or  orthodihydroxyphenol 
available 
Allphatic peptide linkage 
* From Feigl, F., Qualitative Analysis by Spot Tests, Amsterdam, Elsevier Publishers, 
3rd edition 1946. Present analyses performed by Mr. John Cary. The limits of determination 
with known compounds were 4 per cent for the alcohols and 1 per cent for the other tests. 
strip. Therefore a portion of the active pool was dried, redissolved, and injected 
into three rats. Acute diastolic depression of 22  to 54 mm. Hg and prolonged 
(15  to  20  minutes)  depression of  10  to  20  mm.  Hg  occurred.  The  originally 
active dried material from one patient and from the pool were both inactive SCHROEDER, PEltRY, DENNIS, AND  MAHONEY  325 
on the aortic strip. On the other hand, the undried active pool, boiled for 30 
minutes in a water bath, was pressor  in the same three rats and in another, 
with acute or prolonged systolic elevations of 10 to 40 mm. and diastolic of 7 
to 30  ram.  without being acutely depressor  as is  usual with unboiled  crude 
extracts. 
Effect of Alkali and Acid.--Heating  at 100°C. for 30 minutes at pH 8.8 or 
greater destroyed the material when sodium  hydroxide, borate, citrate, and 
carbonate were the alkalis.  No change in activity was caused by heating at 
various pH's from 7 to 2.0. Heating with sodium acetate and  disodium hy- 
drogen phosphate at pH 7.6 diminished the activity by 40  and 50 per cent 
respectively.  When high concentrations of potassium ion  were used  as  the 
alkali, a rapid norepinephrine-like  contraction occurred. 
Effect  of Inorganic Ions  on  the  Test System.--Since  dipotassium hydrogen 
phosphate caused constriction of the aortic strip, a number of simple inorganic 
ions were tested. Relatively high concentrations of sodium ion (0.07 to 0.1 5) 
added to the isotonic bath caused slight constriction when given as the chlo- 
ride, borate, carbonate, and acetate; smaller concentrations (0.05 to 0.01 ~r) 
did not. Borate was slightly more active in this respect.  Alteration of the pH 
of the bath to alkaline caused some constriction.  Potassium chloride caused 
stepwise constriction of the "rapid" type as the concentration was increased 
from 0.02 to 0.1 ~; dipotassinm hydrogen phosphate was more potent, effects 
being considerable at 0.005 M and being marked at 0.05 M solutions. Disodium 
hydrogen phosphate was  constrictor very slightly and transiently (0.05 M), 
trisodinm phosphate (0.015 to 0.003) slightly more so; but these high concen- 
trations changed the pH. The dichlorides  of magnesium,  iron,  cobalt,  chro- 
mium, zinc, copper, and mercury and the citrate of manganese had no demon- 
strable depressant effect upon the strip in concentrations of 0.0005 ~. 
The test system was therefore affected by high concentrations of potassium 
ion, by alkalinity, and by hypertonicity. It was not affected by phosphate nor 
by the other inorganic cations and anions tested. 
Dissimilarity of the Active Material and Potassium Ion.--On the remote pos- 
sibility that potassium ion in the active material might cause constriction of 
the strip,  all pharmacological  tests were performed  on inactivated heated ex- 
tracts made alkaline to pH 8.8 with dipotassium hydrogen phosphate in high 
concentrations. The potassium ion alone or in the mixture caused  a  typical 
rapid reaction as opposed to the slow reaction of the active principle.  Dihy- 
droergotamine markedly enhanced the reaction caused by potassium; atropine 
had no effect in high concentrations,  and pyribenzamine and iproniazid caused 
slight enhancement; these  reactions  differed  from those observed  with the 
active  material.  It  was  probable,  therefore,  that  activity was  not  caused 
solely by potassium nor by any of the other metal ions tested. 
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lation with a  dipeptide (15,  16),  samples of the active pool were mixed with 
various metal salts at concentrations of 0.01  M and allowed to stand.  Signifi- 
cant  depression  of  activity was  caused  immediately by manganous  citrate, 
which abolished it completely on standing at room temperature for 24 hours. 
Adding manganous ion at the height of the reaction was also depressor. This 
effect could not be reversed by large concentrations of ethylenediaminetetra- 
TABLE II 
Inactivation of Pheyentasin by Metal Ions and Metal-Binding Agents 
Estimated activity,  aer cent of control values. 
Mg~ 
Cr++ 
Mn++ 
Fe  ++ 
Co  ++ 
Cu  ++ 
Zn++ 
Substance 
Hg  ++ 
None 
Hydralazine 
NaSCN 
Na~Fe(CN) 6NO 
NaN3 
8-Hydroxyquinoline 
Na~H,EDTA 
Cysteine 
Immediate 
91 
187 
45 
7O 
59 
96 
84 
168 
I00 
46 
i00 
ii0 
89 
35 
I00 
I00 
4 to 5 hrs.  24 hrs. 
130  61 
180  12 
17  0 
134  58 
50  50 
107  27 
137  54 
51  115 
100  100 
20 (2)*  0 (18) 
0 (1%) 
0 (2) 
0 (2) 
0 (1) 
o (3) 
lOO (120) 
Boiled 
after 24 
hrs. 
0 
0 
0 
0 
0 
27 
0 
80 
Color developed 
0 
0 
Pink cloudy 
0 
Faint pink 
0 
0 
0 
0 
Deep blue 
Yellow-orange 
0 
0 
Pale green 
0 
0 
All metals were added to the active material in 0.01 ~ concentrations, giving a final con- 
centration in the 20 ml. bath of 0.0005 ~¢. The binding agents were added in 2 to 5 nag. amounts 
per ml. extract. None of the metal ions alone affected the test system at 0.0005 M concentra- 
tions. Figures in italics represent more than 50 per cent inhibition. 
* The figures in parentheses indicate the number of hours  of incubation at room  tem- 
perature when different from that shown at the top of the column. 
acetate. After 24 hours partial inactivation occurred with cupric and chromous 
chlorides, while little or none was produced by magnesium,  ferrous, zinc,  co- 
baltous, and mercuric chlorides (Table II). Boiling with the metal after stand- 
ing 24 hours destroyed the material in all cases save with zinc. Manganous ion 
also rapidly inactivated guanidine and angiotonin. 
Effect  of  Metal-Binding  Agents.--Because  hydralazine  and  certain  other 
antihypertensive drugs  have  in  common  the  ability to  combine  with  some 
trace metals (13, 22), experiments were designed to ascertain the effect of these SCHROEDER,  PERRY,  DENNIS,  AND  MAHONEY  327 
binding and chelating agents upon the active principle. When 5 rag. of  hy- 
dralazine was mixed at room temperature with 1.0 ml. of extract, 80 per cent 
of the activity was abolished in 2 hours and all in 18 hours, while untreated 
extract was not affected, even on standing for 5 days. A deep blue color de- 
veloped. Iproniazid, however, failed to inactivate the material on standing or 
to produce a color. Smaller concentrations of sodium thiocyanate (2.0 rag.) com- 
pletely inactivated the material after 90 minutes at room temperature, with 
the production of an orange-yellow color and  8-hydroxyquinoline (2.0  rag.) 
inactivated it in 60 minutes with the development of a  light greenish color. 
Sodium nitroprusside (2.0 rag.) and sodium azide (2.0 mg.) likewise inactivated 
the material on standing for 2 hours without change in color. Disodium ethyl- 
enediaminetetraacetate  (5.0  rag.)  completely inactivated  the  substance  on 
standing for 3  hours without change in color.  Cysteine was ineffective and 
/3-mercaptopropionic acid either failed to change activity in small concentra- 
tions or was toxic to the strip in larger amounts (Table II). When added to the 
muscle  constricted  by  the  active  material,  only 8-hydroxyquinoline slowly 
depressed the strip in a manner similar to that produced by hydralazine. The 
constricting effect of norepinephrine was abolished only by azide and nitro- 
prusside of the six substances tested. 
In view of the possibility that a  metal caused the changes in color, ferric, 
zinc, cobaltous, cupric, vanadyl, and nickel salts in s~mall concentrations were 
mixed with hydralazine,  8-hydroxyquinoline, thiocyanate,  ethylenediamine- 
tetraacetate,  and  nitroprusside.  Colors  were  immediately produced  by  the 
ferric salt with the first three substances, which were identical to those de- 
veloping slowly when the same binding agent was mixed with the extract; 
none of the other metals gave similar colors.  The spectra of the ferric com- 
plexes and those of the extracts were not comparable when measured by the 
Beckman spectrophotometer. 
Evidence for  Primary  Amine  Configuration.--While chemical  spot  tests 
showed the presence of primary amine, confirmatory evidence was offered by 
inactivation of the material by nitrous acid and ninhydrin. In 30 minutes at 
room temperature,  0.018 M nitrous acid inhibited activity by one-half; dou- 
bling this concentration suppressed it completely.  A relationship between the 
concentration of acid and inactivation was demonstrated over this interval of 
time, but in 4 hours 0.005  ~  acid destroyed the material.  Ninhydrin (1  per 
cent)  caused a  yellow color  to appear  and  inactivated the constrictor  sub- 
stance. A biuret reaction, however, was consistently negative. 
Evidence for Carbonyl Group.--Hydralazine, a  carbonyl as well as a  metal- 
binding agent, was first used to treat hypertension because pherentasin ap- 
parently contained a  carbonyl group essential to prolonged pressor activity 
(3)  and was inactivated by the drug  (13).  This line of reasoning may have 
been erroneous, in view of the data already presented.  Two other carbonyl 328  PI~ESSOR  SUBSTANCES  IN  ARTERIAL  HYPERTENSION.  V 
reagents were tested. Semicarbazide (also a  hydrazide) which  had  converted 
the prolonged pressor response in the rat to a transient one (3) was mixed with 
the active extract. The reaction between them was apparently gradual and 
dependent partly upon pH; at 7.5  in 2 hours,  the material still gave a  slow 
reaction but at 18 hours a rapid reaction had developed and at 48 hours com- 
plete inactivation had occurred. At pH 4.0 the rapid action was present 72 
hours after mixing. Hydroxylamine, on the other hand, enhanced the rate of 
reaction at acid pH considerably within 30 to 90 minutes of mixing but failed 
to affect it at neutral or slightly alkaline pH after 18 hours. 
Dissimilarity  of  the  Active Material and  Angiotonin  (Hypertensin).--The 
acute pressor action of angiotonin in the rat does not resemble the prolonged 
pressor action of pherentasin. On the aortic strip, however, 1 unit of angioto- 
nin  caused a  typical slow reaction,  but pharmacological and  chemical tests 
differentiated the  two  substances.  (a)  About  one-fiftieth of  the  amount  of 
hydralazine necessary to  inactivate  equiconstrictor doses  of  the  active  ex- 
tract  completely abolished  the  action  of  angiotonin.  (b)  Regitine  caused 
moderate  inactivation.  (c)  Cobalt  chloride and  manganese  citrate  (0.01  M) 
both  immediately  inactivated  angiotonin,  unlike  pherentasin.  Similarities 
only appeared in the susceptibility of both substances to heat at an  alkaline 
pH and stability in acid. It is likely that pherentasin was not angiotonin,  al- 
though similar groups may have been present in the molecules of both. 
Enzymatic Inactivation.--The  alcohol-free constrictor material and the test 
system  were  not  affected by papain,  trypsin,  chymotrypsin, protease,  and 
pepsin.  Papain and cysteine at pH  2 inactivated pherentasin partly and at 
pH 7 completely; cysteine alone had no effect. Renal amine oxidase was  of 
itself  slowly  constrictor;  therefore,  semiquantitative  evaluation  was  neces- 
sary.  A  tenfold  concentration of oxygenated alcohol-free extract  incubated 
with amine oxidase for 30 minutes at 20°C.  caused no greater constriction of 
the strip than with the enzyme alone, while a mixture of the two  applied at 
once  was  considerably  more  active.  Potato  tyrosinase  also  contained  sub- 
stances  constrictor for the  strip  but  did  not  inactivate  the  material,  while 
carboxypeptidase was inert. 
Some hydrolysis at pH 7.6 and 100°C.  for 30 minutes was suggested by the 
observations that regitine and pyribenzamine then caused slight inactivation 
when  added  at  the  height  of  the  reaction.  Dihydroergotamine,  previously 
inert, enhanced activity slightly. This change did not occur when the material 
was heated at pH 2. 
DISCUSSION 
The  present  series  of experiments again  demonstrates  the  presence  of  a 
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substance in 2.25 rag. quantities  s produces a prolonged, slowly developing con- 
strictive action in vitro on the smooth muscle of the rabbit aorta, which disap- 
pears slowly after washing and is remarkably resistant to the usual pharmaco- 
logical blocking or synergistic agents. From the behavior of known vasoactive 
materials on the aortic strip, we can state categorically that the constrictive 
action  was  not  caused  by  the  presence  of  free  tyramine,  norepinephrine, 
epinephrine,  tryptamine,  serotonin,  histamine,  isoamylamine,  cholinergic 
agents or angiotonin. The large quantities of guanidine necessary to cause a 
slow  reaction  (10  to  20  rag.)  and  its  extreme susceptibility to  hydralazine 
(0.1 nag.) definitely exclude this substance as the sole active agent. The presence 
of one or more of these substances in a  peptide linkage, however,  could not 
be excluded. The failure of adrenolytic and sympatholytic substances to block 
the action of the vasoconstrictor substance places it in a  class of compounds 
separate from the sympathomimetic amines and suggests that it acts directly 
upon smooth muscle and not on nervous end organs. 
Failure to find activity in all extracts of hypertensive venous blood is not 
disturbing. Previous studies (2, 3) have shown that more is present in arterial 
blood, indicating that it may be bound to arterial smooth muscle at its site of 
action.  Venous  blood  from  patients  with  severe  hypertension  has  usually 
been active, confirming our impression (5) that the amount present is roughly 
proportional to the severity of the hypertension in terms of the non-neuro- 
genic or nephrogenic component (10). The similarity of the substance found 
in arterial blood extracts to that in venous blood extracts appears established 
by these experiments. 
Some activity has  occasionally been found in arterial  blood from normo- 
tensive patients  suffering from febrile illnesses and  congestive heart  failure 
(5) but none has been demonstrated in extracts from normal individuals (4). 
The  normotensive  venous  pool,  although  inactive,  does  not  constitute  an 
exact control; difficulties in obtaining large quantities of arterial blood from 
normal subjects were insurmountable.  This blood came from Kahn positive 
samples in a blood bank 2 days old and serves only to indicate that pherenta- 
sin is not a product of the processing of the extracts. Other studies have shown 
that it is confined to hypertensive blood. 
Identity of the Active  Substance  with Pherentasin.--As  originally described, 
pherentasin was detected by its prolonged pressor activity in the rat and its 
ability to sensitize the vessels of the rat mesoappendix to  topically applied 
s This material was quite crude (150 mg. dry weight per liter arterial blood). Previous 
intensive efforts to purify pherentasin have yielded  approximately  0.02 rag. per liter of arterial 
blood (4), although losses may have been considerable. The present active material was not 
purified further as the assay method was highly sensitive. It is possible that the biuret test 
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epinephrine  (3).  It is necessary to consider whether or not the present sub- 
stance is indeed pherentasin as extracted previously (1-9). The similarities are 
as follows: (a) Methods of extraction were identical except for the quantities 
and were carried out by the same technicians. (b)  The active pool  here dis- 
cussed caused a prolonged pressor response in rats. (c) Both were inactivated 
by nitrous acid. (d) Both were inactivated by hydralazine, although the ratio 
of susceptibility of the material to the drug was high in the rat and consider- 
ably lower on the aortic strip.  (e)  Hydroxylamine and semicarbazide altered 
its prolonged pressor activity in the  intact rat to a  short acting one (4)  and 
changed it to a substance acting rapidly on the strip.  (f) Both were stable to 
acid and unstable to alkali.  (g)  Both formed complexes  with ninhydrin. (h) 
Ordinary blocking agents were  inactive  on both  test  systems.  It  is  likely, 
therefore, that the substance constricting the rabbit's aortic strip  contained 
the same substance described previously as pressor for the rat. 
Chemical Nature.--Various  hypothetical formulae have been proposed for 
pherentasin (4, 5, 10), all of them representing mere guesses. At least one pri- 
mary amine group  is present  and  necessary  for activity; it  appears  to  be 
terminal. Carbonyl may be present; these experiments do not exclude this pos- 
sibility while previous ones point to it (4).  Sulfur was unexpectedly found in 
large amounts, but it was not in any of the usual organic configurations in the 
dried (inactive) material and may have been a  contaminant. Inactivation by 
manganese, but not by other metallic ions, suggests that a peptide linkage of 
a  specific  type or a  formula RCHNH2CONH, could have been present  (15). 
Inactivation of the polypeptide angiotonin by cobalt ion, for example, is con- 
sistent with one of its known peptide linkages (15, 17). Destruction by papain, 
but not by other proteolytic enzymes, suggests an aliphafic structure in  a 
pepfide bond. 
The susceptibility of pherentasin to inactivation by hydrazides is of little 
aid in determining chemical structure. Hydralazine enhances monamine oxi- 
dase in kidney (18)  and iproniazid inhibits that in smooth muscle of aorta; 
the latter  inhibition enhances the  activity of tymmine (19).  Because both 
hydrazides depressed pherentasin, their effect was probably not the result of 
action on this enzyme. Not too much is known of the mode of vascular action 
of the hydrazides. They are carbonyl reagents and bind certain trace metals 
(13).  They act as antienzymes, for histaminase (20)  and decarboxylase (18), 
and  show  considerable  specificity. They are  bound  to  protein  and  arterial 
mash. The slow  reaction between hydralazine and pherentasin in vitro  sug- 
gests a chemical combination of the active material and the reactive hydrazine 
group; the formation of a  deep blue color may indicate complex formation. 
Hydralazine  did  not  react  directly with  the  primary  amines  tested  (13), 
suggesting another type of linkage with pherentasin. On the other hand, some 
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muscle of the strip in a manner similar to that which dibenamine undergoes, 
since  reaction was  inhibited  by prior application  of  the  drug.  Perhaps  the 
action of hydralazine can best be explained by both types, direct chemical 
combination with pherentasin and  direct binding  to arterial smooth muscle. 
Inactivation of pherentasin in time by six substances having in common the 
ability to bind metals suggests metal binding is related to inactivation. There 
are  three possible explanations:  (a)  Iron was present as a  contaminant and 
inactivation was not related thereto.  (b)  The reaction of the binding agents 
caused  secondary inactivation  of pherentasin  by  release  of  some  unknown 
reactive substance  previously complexed.  (c)  Iron  is  present  and  necessary 
for activity. The slow production of color changes by three of these substances, 
identical to those quickly formed with ferric ion, suggests that if iron is in- 
volved, it is quite tightly bound. Another trace metal, however, could be essen- 
tial for activity. 
Only a  rough estimate can therefore be made of the structure of pherenta- 
sin,  based on the available information. It contains a  primary amine group 
on a terminal carbon atom, may have an aliphatic peptide linkage and one or 
more carbonyl groups essential to prolonged activity. Sulfur may be present 
in a configuration sensitive to rapid oxidation. A metal, possibly iron, may be 
bound  to the molecule. In simplest  terms,  the active material may contain 
cysteine or a metabolic derivative and one or more amino acids with a  termi- 
nal active amine. If so, a polypeptide altered by abnormal metabolism might 
be suspected. Under certain circumstances the crude extract has altered from 
a  pressor to a  depressor material, suggesting oxidation of an active group to 
an inactive form. 
Present uncertainties as to structure are due largely to our inability to col- 
lect enough pure material for elementary chemical analysis.  The substance, 
unknown as it is, provides, however, a logical method for basic evaluation of 
antihypertensive compounds not acting on autonomic nerves. In the study of 
these agents it was found that (a) Pherentasin in vitro was inactivated slowly 
by six drugs with antihypertensive actions in man or animals (22). (b) Pheren- 
tasin  disappeared  from blood when  patients  were  treated  successfully with 
hydralazine,  a  metal-binding  agent  which  lowers  blood  pressure  and  may 
increase renal plasma flow (21) in man.  (c) No inactivation was produced in 
vitro  by substances  acting on constrictor nerves.  (d)  The common chemical 
denominator  of  the  substances  destroying  pherentasin  was  their  ability  to 
bind certain trace metals.  (e)  Pherentasin was no longer pressor in rats pre- 
treated with hydralazine (13). 
SUMMARY  AND CONCLUSIONS 
Some  pharmacological  and chemical  qualities of pherentasin, a vasocon- 
strictor  substance procured from human hypertensive blood, were studied by 332  PRESSOR SUBSTANCES IN"  ARTERIAL HYPERTENSION. V 
a new assay method using the spirally cut rabbit aorta. Of a number of drugs 
tested,  six metal-binding agents including hydralazine inactivated the active 
principle. The material was stable in acid but not in alkali. It was destroyed 
by  drying.  Chemical  analysis  and  inactivation  procedures  suggested  the 
presence of primary amine and considerable sulfur; a peptide linkage was sus- 
pected because of inactivation by manganous ion and papain.  The material 
was remarkably resistant  to  most pharmacological  agents  and  appeared  to 
act directly on smooth muscle. 
The authors are deeply appreciative of the help and advice of Dr. Robert F.  Furchgott 
in setting up his method and in evaluation of pharmacological  tests, of Dr. Dean F.  Davies 
for drawing the blood and supervising the processing of the extracts and of Dr. F. C. Meyer 
of Monsanto Chemical Company for the use of facilities for vacuum distillation of the  crude 
alcoholic extracts. 
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